Pharmacotherapy: Statins and new-onset diabetes mellitus—a matter for debate

Nature Reviews Endocrinology

Volumn 8, Issue 3, 2012, Pages 133-134

  Athyros, Vassilios G ^a   Mikhailidis, Dimitri P ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; HUMAN; METHODOLOGY; NOTE; RISK REDUCTION;

ANIMALS; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RISK REDUCTION BEHAVIOR;

EID: 84865147415     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.16     Document Type: Article

References (10)

1. Culver, A. L. et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women’s Health Initiative. Arch. Intern. Med. 172, 144-152 (2012).
2. Sattar, N. et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375, 735-742 (2010).
3. Preiss, D. et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 305, 2556-2564 (2011).
4. Athyros, V. G., Tziomalos, K., Karagiannis, A. and Mikhailidis, D. P. Lipid-lowering agents and new onset diabetes mellitus. Expert Opin. Pharmacother. 11, 1965-1970 (2010).
5. Verdecchia, P. et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43, 963-969 (2004).
6. Athyros, V. G., Tziomalos, K., Karagiannis, A. and Mikhailidis, D. P. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr. Pharm. Des. 16, 3939-3947 (2010).
7. Athyros, V. G. et al. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology http://dx.doi.org/10.1177/0003319711421341.
8. Waters, D. D. et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J. Am. Coll. Cardiol. 57, 1535-1545 (2011).
9. Karagiannis, A. et al. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr. Vasc. Pharmacol. 8, 792-803 (2010).
10. Neil, H. A. et al.; CARDS Study Investigators. Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care 29, 2378-2384 (2006).